Fundraising Fox

Breyer Capital2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Atropos Healthatroposhealth.comin𝕏May 2024 · $33M

Atropos Health develops a cloud-based platform that generates real-world evidence from electronic health records to inform clinical decision-making and healthcare research.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechStanford, US

Nigam Shah(Co-Founder & Chief Data Scientist)Brigham Hyde(Co-Founder & Chief Executive Officer)Saurabh Gombar(Co-Founder & Chief Medical Officer)inNEIL SANGHAVI(Executive Officer)

BoardMATTHEW BETTONVILLE(Director)JAMES BREYER(Director)in

Co-investorsYosemiteCencora VenturesCerity Partners Venturesmark vcMcKesson VenturesPresidio Ventures+2 more

Firewallusefirewall.com𝕏Mar 2024 · $3.7M

Firewall is building smart contract network technology that embeds anti-theft rules into the protocol level, aiming to prevent criminals from stealing user funds.

Crypto & Web3Cybersecurity

Co-investorsNIVHack VC

Opacityopacity.networkin𝕏Mar 2024

Opacity provides infrastructure for issuing compliant financial products with global distribution and liquidity through decentralized finance integration, targeting capital markets participants.

Crypto & Web3FintechNew York, US

Andrew Bledsoe(Executive Officer)

BoardAaron Marz(Director)Hersh Patel(Director)

Co-investorsArchetypeDepartment of XYZEv3 Ventures LlcGD1Inception Capital (ex OP Crypto)Marin Digital Ventures+2 more

Suki Redwood Citysuki.aiinOct 2024 · $70M

Suki develops AI technology that assists clinicians with administrative tasks and documentation, enabling healthcare providers to focus more on patient care and clinical work.

AI & Machine LearningDigital HealthHealthtech

Punit Soni(Founder & CEO)Punit Singh Soni(Founder)in

Co-investorsEpsilon Health InvestorsFlare Capital PartnersHealthier CapitalInHealth VenturesMarch Capital PartnersHedosophia+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.